Economic aspects of diabetic foot care in a multidisciplinary setting: A review

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 5, 2007, Pages 339-347

  Matricali, Giovanni A ^a,c   Dereymaeker, Greta ^b   Muls, Erik ^a   Flour, Maria ^a   Mathieu, Chantal ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Heilig Hartziekenhuis ^*  (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cost effectiveness; Diabetes mellitus; Diabetic foot; Multidisciplinary care; Review

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETES CONTROL; DIABETIC FOOT; DISEASE SEVERITY; DRUG COST; FOOT AMPUTATION; FOOT CARE; FOOT ULCER; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFECTION; LENGTH OF STAY; MEDICARE; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROBABILITY; REIMBURSEMENT; REVIEW;

COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETIC FOOT; FOOT DISEASES; HUMANS; PREVALENCE;

EID: 34547128647     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.706     Document Type: Review

References (58)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes; estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
2. International Consensus on the Diabetic Foot. In International Working Group on the Diabetic Foot ed, edn. International Working Group on the Diabetic Foot: Amsterdam, 1999; 7-25.
3. American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care 1999; 22: 1354-1360.
4. Apelqvist J, Larsson J, Agardh C-D. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485-491.
5. Apelqvist J, Ragnarson-Tenvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995; 16: 388-394.
6. Bloomgarden ZT. The european association for the study of diabetes annual meeting, 1998 - complications of diabetes. Diabetes Care 1999; 22: 1364-1370.
7. Bouter KP, Storm AJ, de Groot RRM, Uitslager R, Erkelens DW, Diepersloot PUA. The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome. Eur J Med 1993; 2: 215-218.
8. Larsson J, Apelqvist J. Toward less amputations in diabetic patients: incidence, causes, cost, treatment, and prevention - a review. Acta Orthop Scand 1995; 66: 181-192.
9. Larsson J, Apelqvist J, Agardh C-D, Stenström A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995; 12: 770-776.
10. Lindegård P, Jönsson B, Lithner F. Amputations in diabetic patients in Gotland and Umeå counties 1971-1980. Acta Med Scand 1984; 687(Suppl.): 89-93.
11. Lithner F. Epidemiology and economic impact of the diabetic foot - a major health care problem. In The Diabetic Foot. Proceedings of the 1th International Symposium on the Diabetic Foot, Bakker K, Nieuwenhuijken Kruseman AC (eds). Excerpta Medica: Amsterdam, 1991; 9-17.
12. Macleod AF, Williams DRR, Sonksen PH, Boulton AJM. Risk factors for foot ulcers in diabetic patients attending a hospital clinic. Diabetologia 1991; 34: 154.
13. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6: 87-91.
14. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22: 382-387.
15. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In Levin and O'Neal's The Diabetic Foot (6th edn), vol. 2, Bowker JH, Pfeifer MA (eds). Mosby: Saint Louis, MN, 2001; 13-32.
16. Smith DM, Weinberger M, Katz BP. A controlled trial to increase office visits and reduce hospitalizations of diabetic patients. J Gen Intern Med 1987; 2: 232-238.
17. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002; 45: S13-S17, DOI: 10.1007/s00125-002-0859-9.
18. Levin ME. The diabetic foot: pathophysiology, evaluation, and treatment. In The Diabetic Foot (4th edn), vol 1, Levin ME, O'Neal LW (eds). Saint Louis, MN: Mosby: 1988; 1-50.
19. Van Acker K, Oleen-Burkey M, De Decker L, et al. Cost and resource utilization for prevention and treatment of foot lesions in a diabetic foot clinic in Belgium. Diabetes Res Clin Pract 2000; 50: 87-95.
20. Henriksson F, Jönsson B. Diabetes: the cost of illness in Sweden. J Intern Med 1998; 244: 461-468.
21. Jönsson B, Persson U. A Study in Health Economics, vol 7. The Swedish Institute for Health Economics: Meddelande, 1981; 1-109.
22. Ragnarson-Tenvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis 2004; 39: S132-S139.
23. Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJV. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments. Diabetes Metab 2004; 30: 549-556.
24. Price P, Harding K. The impact of foot complications on health-related quality of life in patients with diabetes. J Cutan Med Surg 2000; 4: 45-50.
25. Bowker JH, Wade NP. Organizing an education-based diabetic foot clinic. In Levin and O'Neal's the Diabetic Foot (6th edn), vol 30, Bowker JH, Pfeifer MA (eds). Saint Louis, MN: Mosby: 2001; 657-664.
26. van Houtum WH, Rauwerda JA, Ruwaard D, Schaper NC, Bakker K. Reduction in diabetes-related lower-extremity amputations in the Netherlands: 1991-2000. Diabetes Care 2004; 27: 1042-1046.
27. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes - epidemiology and prevention. Diabetes Care 1989; 12: 24-31.
28. Davidson JK, Alogna M, Goldsmith M, Borden J. Assessment of program effectiveness at Grady Memorial Hospital - Atlanta. In Educating Diabetic Patients, vol 35, Steiner G, Lawrence PA (eds). Springer: New York, 1981; 329-348.
29. Edmonds ME, Blundell MP, Morris ME, Mealor Thomas E, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialised foot clinic. Q J Med 1986; 232: 763-771.
30. Faglia E, Favales F, Aldeghi A, et al. Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J Diabetes Complications 1998; 12: 96-102.
31. Falkenberg M. Metabolic control and amputations among diabetics in primary health care - a population-based intensified programme governed by Patient Education. Scand J Prim Health Care 1990; 8: 25-29.
32. Frykberg RG. The team approach in diabetic foot management. Adv Wound Care 1998; 11: 71-77.
33. Gibbons GW, Marcaccio EJ, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs 1990- reduced length of stay and costs, insufficient reimbursement. Arch Surg 1993; 128: 576-581.
34. Griffith GD, Wieman TF. Meticulous attention to foot care improves the prognosis in diabetic ulceration of the foot. Surg Gynecol Obstet 1992; 174: 49-51.
35. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA, Bunt TJ. Prevention of amputation by diabetic education. Am J Surg 1989; 158: 520-524.
36. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 1984; 21: 2161-2177.
37. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med 1998; 15: 80-84.
38. Mason J, O'Keeffe C, McIntosh A, Hutchinson A, Booth A, Young RJ. A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I: prevention. Diabet Med 1999; 16: 801-812.
39. Jeffcoate W. The incidence of amputation in diabetes. Acta Chir Belg 2005; 105: 140-144.
40. Apelqvist J, Ragnarson-Tenvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting -an economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235: 463-471.
41. Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 1998; 21: 42-48.
42. Holzer SES, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 1998; 20: 169-181.
43. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower extremity ulcers. Diabetes Care 2000; 23: 1333-1338.
44. Ragnarson-Tenvall G, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000; 18: 225-238.
45. Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care 2004; 27: 2129-2134.
46. Matricali GA, Deroo K, Dereymaeker G. Outcome and recurrence rate of diabetic foot ulcers treated by a total contact cast: short-term follow-up. Foot Ankle Int 2003; 24: 680-684.
47. Ragnarson-Tenvall G, Apelqvist J. Cost-effective management of diabetic foot ulcers. Pharmacoeconomics 1997; 12: 42-53.
48. Ollendorf DA, Kotsanos JG, Whisner WJ, et al. Potential economic benefits of lower-extremity amputations prevention strategies in diabetes. Diabetes Care 1998; 21: 1240-1245.
49. Horswell RL, Birke JA, Patout CA. A staged management diabetes foot program versus standard care: A 1-year cost and utilization comparison in a state public hospital system. Arch Phys Med Rehabil 2003; 84: 1743-1746, DOI:10.1016/S0003-9993(03)00477-5.
50. Klenerman L, McCabe C, Cogley D, Crerand S, Laing P, White M. Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic. Diabet Med 1996; 13: 561-563.
51. Lamotte M, Annemans L, Peys F. Ethische en Economische Aspecten van de Diabetesvoet in België. Belgisch Instituut Gezondheids Economie: Brussels, 2001; 6-8, Briefing September.
52. Lamotte M, Annemans L, Peys F. Gezondheidseconomishe Aspecten van Interventies in de Preventie en Behandeling van Diabetes in België Belgisch Instituut Gezondheids Economie: Brussels, 2001; 1-8, Briefing March.
53. Ragnarson-Tenvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 2001; 44: 2077-2087, DOI:∼10.1007/s001250100013.
54. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot. Diabetes Care 2004; 27: 901-907.
55. Palmer AJ, Roze S, Valentine WJ, et al. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004; 20: S5-S26, DOI: 10.1185/030079904X1980.
56. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13: 397-409.
57. International Consensus on the Diabetic Foot. International Working Group on the Diabetic Foot ed. International Working Group on the Diabetic Foot: Amsterdam, 1999; 73-74.
58. Haentjens P, Annemans L. Health economics and the orthopaedic surgeon. J Bone Joint Surg 2003; 85-B: 1093-1099, DOI:10.1302/ 0301-620X.85B8.14629 $2.00.